ACH (Accendra Health) Long-Term Debt: $1,522 Mil (As of Mar. 2026)


ACH Accendra Health Inc ACH
61 GF Score
Price $3.59
GF Value $5.02
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Accendra Health Long-Term Debt?

Accendra Health ACH +0.28% 61 Long-Term Debt is $1,522 Mil as of Mar. 2026. GuruFocus rates ACH with a GF Score™ of 61/100 and a GF Value™ of $5.02 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Accendra Health's Long-Term Debt for the quarter that ended in Mar. 2026 was $1,522 Mil.

Accendra Health's quarterly Long-Term Debt declined from Sep. 2025 ($1,835 Mil) to Dec. 2025 ($1,800 Mil) and declined from Dec. 2025 ($1,800 Mil) to Mar. 2026 ($1,522 Mil).

Accendra Health's annual Long-Term Debt declined from Dec. 2023 ($1,891 Mil) to Dec. 2024 ($1,798 Mil) but then increased from Dec. 2024 ($1,798 Mil) to Dec. 2025 ($1,800 Mil).

Accendra Health  (NYSE:ACH) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Accendra Health Long-Term Debt Related Terms

Accendra Health Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Accendra Health's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Long-Term Debt Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 947.54 2,482.97 1,890.60 1,798.39 1,799.88

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,897.52 1,594.75 1,835.26 1,799.88 1,521.94
ACH
61GF Score
Accendra Health Inc ACH
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $1,522 Mil mean?
Accendra Health (ACH) has a Long-Term Debt of $1,522 Mil as of Mar. 2026.
Is Accendra Health's Long-Term Debt too high?
Accendra Health's current Long-Term Debt is $1,522 Mil. Overall, Accendra Health has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Long-Term Debt compare to FOCL and YI?
Accendra Health's Long-Term Debt of $1,522 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Accendra Health's current Long-Term Debt is $1,522 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.02, compared to a current price of $3.59 — trading 28.5% below its estimated fair value. The current Long-Term Debt is $1,522 Mil. Accendra Health's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Accendra Health (ACH), the current Long-Term Debt is $1,522 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.59 is trading 28.5% below its estimated GF Value™ of $5.02. GuruFocus considers Accendra Health to be Modestly Undervalued.

Key valuation signals for ACH:

  • Long-Term Debt: $1,522 Mil
  • GF Value™: $5.02 vs. price of $3.59 (28.5% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
61GF Score

Get the complete analysis for ACH

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.59
Price
$5.02
GF Value